170 related articles for article (PubMed ID: 28668379)
1. Design and optimization of PLGA microparticles for controlled and local delivery of Neuregulin-1 in traumatic spinal cord injury.
Santhosh KT; Alizadeh A; Karimi-Abdolrezaee S
J Control Release; 2017 Sep; 261():147-162. PubMed ID: 28668379
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the neuregulin-1-ErbB network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury.
Gauthier MK; Kosciuczyk K; Tapley L; Karimi-Abdolrezaee S
Eur J Neurosci; 2013 Sep; 38(5):2693-715. PubMed ID: 23758598
[TBL] [Abstract][Full Text] [Related]
3. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury.
Wang YC; Wu YT; Huang HY; Lin HI; Lo LW; Tzeng SF; Yang CS
Biomaterials; 2008 Dec; 29(34):4546-53. PubMed ID: 18774604
[TBL] [Abstract][Full Text] [Related]
4. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ
J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169
[TBL] [Abstract][Full Text] [Related]
5. Combination of chondroitinase ABC, glial cell line-derived neurotrophic factor and Nogo A antibody delayed-release microspheres promotes the functional recovery of spinal cord injury.
Zhang Y; Gu Z; Qiu G; Song Y
J Craniofac Surg; 2013 Nov; 24(6):2153-7. PubMed ID: 24220426
[TBL] [Abstract][Full Text] [Related]
6. Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering.
Díaz-Herráez P; Garbayo E; Simón-Yarza T; Formiga FR; Prosper F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):143-50. PubMed ID: 23958325
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury.
Baumann MD; Kang CE; Tator CH; Shoichet MS
Biomaterials; 2010 Oct; 31(30):7631-9. PubMed ID: 20656347
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
9. Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.
Kang CE; Baumann MD; Tator CH; Shoichet MS
Cells Tissues Organs; 2013; 197(1):55-63. PubMed ID: 22796886
[TBL] [Abstract][Full Text] [Related]
10. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
11. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
13. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia.
Formiga FR; Garbayo E; Díaz-Herráez P; Abizanda G; Simón-Yarza T; Tamayo E; Prósper F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):665-72. PubMed ID: 23523545
[TBL] [Abstract][Full Text] [Related]
14. Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs).
Lee YS; Lim KS; Oh JE; Yoon AR; Joo WS; Kim HS; Yun CO; Kim SW
J Control Release; 2015 May; 205():128-33. PubMed ID: 25575866
[TBL] [Abstract][Full Text] [Related]
15. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
Hu Y; Hollinger JO; Marra KG
J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
[TBL] [Abstract][Full Text] [Related]
16. Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles.
Ren H; Han M; Zhou J; Zheng ZF; Lu P; Wang JJ; Wang JQ; Mao QJ; Gao JQ; Ouyang HW
Biomaterials; 2014 Aug; 35(24):6585-94. PubMed ID: 24811262
[TBL] [Abstract][Full Text] [Related]
17. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
[TBL] [Abstract][Full Text] [Related]
18. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2 : I. Effects of some formulation parameters on microparticle characteristics.
Devrim B; Bozkir A; Canefe K
J Microencapsul; 2011; 28(6):582-94. PubMed ID: 21827360
[TBL] [Abstract][Full Text] [Related]
20. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
